CytomX Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/18/2026

1. XENE
2. SPY
3. HUBS
4. NUE
5. ONON
6. AAPL
7. TRMD
8. AZN
9. NVDA
10. RARE

Go back to CytomX Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update

CytomX Therapeutics (CTMX) Tops Q2 EPS by 17c

August 8, 2023 4:29 PM EDT

CytomX Therapeutics (NASDAQ: CTMX) reported Q2 EPS of ($0.02), $0.17 better than the analyst estimate of ($0.19). Revenue for the quarter came in at $24.7 million versus the consensus estimate of $13.68 million.

For earnings history and earnings-related data on CytomX Therapeutics (CTMX) click here.

... More